Press Release / Media Release

| Updated on March 13, 2018

JDRF Supports Biocon Study of Novel, Fast-acting Oral Insulin Tregopil for Type 1 Diabetes Treatment.

Pdf Link: Press Release / Media Release

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on September 06, 2017
This article is closed for comments.
Please Email the Editor